MULTIDRUG RESISTANT PULMONARY TUBERCULOSIS
Clinical trials for MULTIDRUG RESISTANT PULMONARY TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new MULTIDRUG RESISTANT PULMONARY TUBERCULOSIS trials appear
Sign up with your email to follow new studies for MULTIDRUG RESISTANT PULMONARY TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a 6-Month pill combo beat Drug-Resistant TB?
Disease control Not yet recruitingThis study tests whether a 6-month combination of four drugs (bedaquiline, delamanid, linezolid, and levofloxacin) works as well as the standard longer treatment for drug-resistant tuberculosis. Fifty-two adults in Hubei, China will be randomly assigned to either the short or sta…
Matched conditions: MULTIDRUG RESISTANT PULMONARY TUBERCULOSIS
Phase: NA • Sponsor: Wuhan Pulmonary Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New 6-Month TB drug combo tested in diabetic patients
Disease control Not yet recruitingThis study tests a 6-month treatment regimen containing pretomanid for people with drug-resistant tuberculosis who also have type 2 diabetes. Researchers will compare how well the treatment works and how safe it is in diabetic patients versus non-diabetic patients. The goal is to…
Matched conditions: MULTIDRUG RESISTANT PULMONARY TUBERCULOSIS
Sponsor: Wuhan Pulmonary Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC